Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmaquin in non-CF bronchiectasis (ORBIT-4)
NCT02104245Phase 3Completed
- Sponsor
- Paradigm Biopharmaceuticals
- Start
- May 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of Ciprofloxacin for Inhalation in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Paradigm Biopharmaceuticals. Started May 2014; status: completed.
02
Drugs
Ciprofloxacin for Inhalation
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02104245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104245.